Table 5.
1.5 years after registration starts | 2.5 years after registration starts | Whether research fundsa have been obtained | Decision for early termination due to low accrual |
---|---|---|---|
Less than 20% of planned accrual pace | – | None | ✔ Trial termination in principle |
Obtained |
✔ Trial termination or downsizing of sample size not mandated; a grace period of 1 year for accrual is provided ✔ The research group establishes criteria for the number of accruals to be achieved after 1 year ✔ The number of accruals is re-evaluated after 1 year to determine if the criteria are met |
||
– | Less than 50% of planned accrual pace | None |
✔ Trial termination in principle ✔ If it is desired to continue the trial, downsizing will be conducted through protocol revision ✔ If downsizing results in a detection power of less than 50% for clinically meaningful differences, the trial will be terminated |
Obtained |
✔ Trial termination or downsizing of sample size not mandated; a grace period of 1 year for accrual is provided ✔ The research group establishes criteria for the number of accruals to be achieved after 1 year ✔ The number of accruals is re-evaluated after 1 year to determine if the criteria are met |
||
20% or more of planned accrual pace | 50% or more of planned accrual pace | – | ✔ Trial continues |
aOther than the National Cancer Center Research and Development Funds